glutathione in ovarian cancer a double-edged sword

glutathione in ovarian cancer a double-edged sword Targeting ferroptosis cancer: Novel strategies to overcome chemotherapy resistance Frontiers | Ferroptosis: a dual-edged

Name: glutathione in ovarian cancer a double-edged sword Targeting ferroptosis cancer: Novel strategies to overcome chemotherapy resistance Frontiers | Ferroptosis: a dual-edged
Brand: aimoneimmobiliare.it
SKU: 27314239286
Price: 20.37 USD
Availability: InStock
Rating: 4.1413 (30 reviews)

Frontiers Ferroptosis: a dual edged sword in tumour growth Frontiers Glutamine's double edged sword: fueling tumor growth and offering therapeutic hope Glutathione: Lights and Shadows in Cancer Patients N Acetyl Cysteine as a promising therapeutic approach in ovarian cancer: potential and perspectives PMC Metabolic reprogramming of three major nutrients in platinum resistant ovarian cancer PMC

SKU: 27314239286 · From aimoneimmobiliare.it

4.1

USD20.37 USD43.37

Pay in 4 interest-free payments of $5.09 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

doi:10.1016/j.arr.2022.101766

doi: 10.1074/jbc.M009093200

doi: 10.1016/j.bbrep.2016.06.017

doi: 10.3390/antiox12030548 92 LiJJiaYCDingYXBaiJCaoFLiF

Compared to healthy controls, SCD patients have significantly lower erythrocyte GSH and cysteine concentrations 12 and a faster rate of GSH synthesis, suggesting that the endogenous cysteine supply is insufficient to meet all anabolic demands